Dan T
Senior Vice President & General Counsel
pharmaceutics
gsk plc.
Switzerland
Biography
Dan is Senior Vice President & General Counsel and a member of the Corporate Executive Team. Dan joined GSK in September 2008 and is responsible for leading the company’s legal department in protecting GSK’s intellectual property; managing litigation; supporting business development transactions; and business compliance and risk management. In 2012, Dan led the integration team following the acquisition of Human Genome Sciences, which later resulted in the launch of Benlysta, the first lupus treatment in 50 years. Dan heads GSK’s Contributions Committee in the US and also led the Government Affairs, Public Policy and Patient Advocacy team from 2012 until 2014. Dan is Senior Vice President & General Counsel and a member of the Corporate Executive Team. Dan joined GSK in September 2008 and is responsible for leading the company’s legal department in protecting GSK’s intellectual property; managing litigation; supporting business development transactions; and business compliance and risk management. In 2012, Dan led the integration team following the acquisition of Human Genome Sciences, which later resulted in the launch of Benlysta, the first lupus treatment in 50 years. Dan heads GSK’s Contributions Committee in the US and also led the Government Affairs, Public Policy and Patient Advocacy team from 2012 until 2014.
Research Interest
pharmaceutics
